|
Calcimedica Inc (NASDAQ: CALC) |
|
Calcimedica Inc
CALC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Calcimedica Inc 's sales fell
in III. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 9.73 %
Calcimedica Inc net loss increased from $-5 millions, to $-6 millions in III. Quarter 2024,
• More on CALC's Growth
|
|
Calcimedica Inc realized a net loss in trailing twelve months.
Calcimedica Inc realized cash reduction of $ -0.22 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.15.
• More on CALC's Valuation
|
|
|
|
|
Calcimedica Inc realized net loss in trailing twelve months.
Calcimedica Inc realized cash outflow of $ -0.22per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.15.
Calcimedica Inc Price to Book Ratio is at 3.44 lower than Industry Avg. of 79.01. and higher than S&P 500 Avg. of 0.01
• More on CALC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com